Literature DB >> 8152693

The role of nuclear cardiology in hypertension.

S D Pringle1, F G Dunn, A R Lorimer, J H McKillop.   

Abstract

In view of the increased risk of cardiac events in systemic hypertension, particularly in patients with left ventricular hypertrophy, it is important to have reliable methods of assessing cardiac structure and function and myocardial perfusion in these patients. While echocardiography is the noninvasive method of choice for measuring the severity of left ventricular hypertrophy there is no alternative at present to invasive coronary angiography to define accurately coronary artery anatomy. Nuclear cardiological investigations are extremely useful in the assessment of systolic and diastolic function at rest and during exercise. Furthermore, myocardial perfusion imaging is of value in identifying myocardial ischaemia and assessing the functional importance of coronary artery lesions. Recent studies have also suggested that nuclear cardiology investigations may be the best way to identify nonfunctioning but viable areas of the myocardium which may benefit from revascularization.

Entities:  

Mesh:

Year:  1994        PMID: 8152693     DOI: 10.1097/00006231-199401000-00002

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease.

Authors:  A Elhendy; R T van Domburg; F B Sozzi; D Poldermans; J J Bax; J R Roelandt
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 2.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

3.  Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis.

Authors:  Luca Nai Fovino; Giorgio Saladini; Anna Rita Cervino; Francesca Saladini; Michele Gregianin; Renato Razzolini; Laura Evangelista
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

Review 4.  [Cardiac sequelae of hypertension].

Authors:  M Steinmetz; G Nickenig
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.